Accessibility Menu
 
TherapeuticsMD logo

TherapeuticsMD

(NASDAQ) TXMD

Current Price$2.17
Market Cap$24.42M
Since IPO (2011)-96%
5 Year-97%
1 Year+72%
1 Month+6%

TherapeuticsMD Financials at a Glance

Market Cap

$24.42M

Revenue (TTM)

$3.02M

Net Income (TTM)

$569.00K

EPS (TTM)

$-0.05

P/E Ratio

-42.80

Dividend

$0.00

Beta (Volatility)

1.11 (Average)

Price

$2.17

Volume

14,330.226

Open

$2.10

Previous Close

$2.11

Daily Range

$2.04 - $2.17

52-Week Range

$0.98 - $2.95

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TherapeuticsMD

Industry

Pharmaceuticals

Employees

1

CEO

Marlan D. Walker

Headquarters

Boca Raton, FL 33431, US

TXMD Financials

Key Financial Metrics (TTM)

Gross Margin

70%

Operating Margin

-1%

Net Income Margin

-19%

Return on Equity

-2%

Return on Capital

-12%

Return on Assets

-2%

Earnings Yield

-2.34%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$24.42M

Shares Outstanding

11.57M

Volume

14.33K

Avg. Volume

27.77K

Financials (TTM)

Gross Profit

$1.83M

Operating Income

$4.21M

EBITDA

$3.02M

Operating Cash Flow

$2.45M

Capital Expenditure

$0.00

Free Cash Flow

$2.45M

Cash & ST Invst.

$7.48M

Total Debt

$5.12M

TherapeuticsMD Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$893.00K

+33.9%

Gross Profit

$13.00K

-101.9%

Gross Margin

-1.46%

N/A

Market Cap

$24.42M

N/A

Market Cap/Employee

$24.42M

N/A

Employees

1

N/A

Net Income

$619.00K

-345.6%

EBITDA

$2.26M

-965.6%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$2.36M

+211.6%

Accounts Receivable

$3.52M

-1.0%

Inventory

$0.00

N/A

Long Term Debt

$5.12M

-7.6%

Short Term Debt

$0.00

-100.0%

Return on Assets

-1.51%

N/A

Return on Invested Capital

-11.84%

N/A

Free Cash Flow

$1.37M

+11350.0%

Operating Cash Flow

$1.37M

+11350.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
MPLTMapLight Therapeutics, Inc.
$31.42+3.72%
AYTUAytu BioPharma, Inc.
$2.57+1.98%
EKSOEkso Bionics Holdings, Inc.
$11.90+4.02%
PMNProMIS Neurosciences, Inc.
$10.97-1.64%

Trending Stocks

Symbol / CompanyPricePrice Chg
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.58+0.09%
MARAMara Holdings
$12.07+0.13%
SOFISoFi Technologies
$16.14+0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.29+0.03%

Questions About TXMD

What is the current price of TherapeuticsMD?

TherapeuticsMD is trading at $2.06 per share.

What is the 52-week range for TherapeuticsMD?

Over the past 52 weeks, TherapeuticsMD has traded between $0.98 and $2.95.

How much debt does TherapeuticsMD have?

As of the most recent reporting period, TherapeuticsMD reported total debt of $6.10M.

How much cash does TherapeuticsMD have on hand?

TherapeuticsMD reported $7.48M in cash and cash equivalents in its most recent financial results.

What is TherapeuticsMD’s dividend yield?

TherapeuticsMD does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.